Pharmaceutical Industry Research Report, Pharma Market

sale

Liver Disease Treatment Market

P

2021

Liver Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

The global liver disease treatment market size was valued at $20,673.70 million in 2020, and is estimated to reach $36,455.70 million by 2030, growing at a CAGR of ...

Report Code : A00295 | Pages : 254 | Category : Life Sciences

Price:

~~$3,712~~ $2,932 (21% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Chagas Disease Treatment Market

U

2026

Chagas Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by kinetoplastid protozoan parasite called Trypanosoma cruzi, which transmits the infectious disease to humans and animals.

Report Code : A05111 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Gastroesophageal Reflux Disease Treatment Market

U

2026

Gastroesophageal Reflux Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Gastroesophageal reflux disease (GERD) is a digestive disorder, which is caused when stomach contents such as acid, food, and fluids reflux to the esophagus. This causes irritation of ...

Report Code : A05289 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Lysosomal Disease Treatment Market

P

2022

Lysosomal Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global lysosomal disease treatment market was valued at $7.6 billion in 2021, and is projected to reach $14.1 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.

Report Code : A05290 | Pages : 319 | Category : Life Sciences

Price:

~~$3,840~~ $2,688 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Fabry’s Disease Treatment Market

U

2026

Fabry’s Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Fabry’s Disease or alpha galactosidase-A deficiency is a rare inherited disorder, as a result of the buildup of particular type of fat, namely globotriaosylceramide inside the body’s cells. ...

Report Code : A11241 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Pelvic Inflammatory Disease Treatment Market

U

2026

Pelvic Inflammatory Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Pelvic inflammatory disease is an infection of the female reproductive organs. The pelvis includes the ovaries, cervix, fallopian tubes, and uterus. Different types of bacteria can cause this ...

Report Code : A11672 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Paget’s disease Treatment Market

U

2026

Paget’s disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

A Paget’s disease, also known as Osteitis deformans, is a chronic bone disorder, which affects a single bone (monostotic) or multiple bones (poly-ostotic) resulting in abnormally long, weak, ...

Report Code : A12067 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Bromhidrosis Disease Treatment Market

U

2026

Bromhidrosis Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Bromhidrosis, also known as osmidrosis, is a condition of abnormal or offensive body odor, determined by apocrine sweat gland secretion, although other sources may play a role. Bromhidrosis ...

Report Code : A12322 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Hirschsprung Disease Treatment Market

U

2026

Hirschsprung Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Hirschsprung disease is known to affect colon and cause problems with stool excretion. This disease is hereditary due to absence of a critical nerve cell in the muscle ...

Report Code : A12655 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Addison’s Disease Treatment Market

U

2026

Addison’s Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Addison’s disease, more commonly known as adrenal insufficiency, is a rare hormonal disorder wherein the adrenal gland produces little cortisol and aldosterone hormone as compared to the amount ...

Report Code : A13327 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Refsum Disease Treatment Market

U

2026

Refsum Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Refsum disease is a genetic disease that is inherited as an autosomal recessive trait. The major cause of refsum disease is the accumulation of fatty acid (phytanic acid) ...

Report Code : A13586 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Polychondritis Disease Treatment Market

U

2026

Polychondritis Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Polychondritis is chronic disease characterized by inflammation and destruction of the cartilage of various tissues of the body. The cause of polychondritis is unknown, but the disease may be the result of an abnormal immune response. Symptoms include pain, redness, and swelling of the affected cartilage.

Report Code : A14847 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Huntington’s Disease Treatment Market

P

2022

Huntington’s Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global huntington's disease treatment market was valued at $315.2 million in 2021, and is projected to reach $707.5 million by 2031, growing at a CAGR of 8.4% from 2022 to 2031.

Report Code : A17522 | Pages : 301 | Category : Life Sciences

Price:

~~$3,840~~ $2,688 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mexico Lysosomal Disease Treatment Market

P

2022

Mexico Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Mexico Lysosomal Disease Treatment Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The Mexico Lysosomal Disease Treatment Market report covers profile of leading stakeholders operating in the Mexico.

Report Code : * A28011 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Lysosomal Disease Treatment Market

P

2022

U.S. Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the U.S. Lysosomal Disease Treatment Market due to the outbreak of COVID-19.

Report Code : * A28012 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Canada Lysosomal Disease Treatment Market

P

2022

Canada Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Canada Lysosomal Disease Treatment Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The Canada Lysosomal Disease Treatment Market report covers profile of leading stakeholders operating in the Canada.

Report Code : * A28013 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Europe Lysosomal Disease Treatment Market

P

2022

Europe Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The current Europe Lysosomal Disease Treatment Market is quantitatively analyzed from 2021 to 2031 to benchmark the financial competency.

Report Code : * A28014 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Germany Lysosomal Disease Treatment Market

P

2022

Germany Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. End User was the leading segment.

Report Code : * A28015 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Italy Lysosomal Disease Treatment Market

P

2022

Italy Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

Report Code : * A28016 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.K. Lysosomal Disease Treatment Market

P

2022

U.K. Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

Research study titled U.K. Lysosomal Disease Treatment Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

Report Code : * A28017 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

France Lysosomal Disease Treatment Market

P

2022

France Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The End User in France Lysosomal Disease Treatment Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Report Code : * A28018 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Spain Lysosomal Disease Treatment Market

P

2022

Spain Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The End User segment in Spain Lysosomal Disease Treatment Market is expected to garner considerable share in terms of value and volume during the forecast period.

Report Code : * A28019 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Lysosomal Disease Treatment Market

P

2022

Japan Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Japan Lysosomal Disease Treatment Market due to the outbreak of COVID-19.

Report Code : * A28021 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

China Lysosomal Disease Treatment Market

P

2022

China Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. End User was the leading segment.

Report Code : * A28022 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Lysosomal Disease Treatment Market

P

2022

Australia Lysosomal Disease Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2031

The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

Report Code : * A28023 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Pharmaceuticals

Filter by Region

Filter by Discounts

Filter by Category

The global liver disease treatment market size was valued at $20,673.70 million in 2020, and is estimated to reach $36,455.70 million by 2030, growing at a CAGR of ...

Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by kinetoplastid protozoan parasite called Trypanosoma cruzi, which transmits the infectious disease to humans and animals.

Gastroesophageal reflux disease (GERD) is a digestive disorder, which is caused when stomach contents such as acid, food, and fluids reflux to the esophagus. This causes irritation of ...

The global lysosomal disease treatment market was valued at $7.6 billion in 2021, and is projected to reach $14.1 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.

Fabry’s Disease or alpha galactosidase-A deficiency is a rare inherited disorder, as a result of the buildup of particular type of fat, namely globotriaosylceramide inside the body’s cells. ...

Pelvic inflammatory disease is an infection of the female reproductive organs. The pelvis includes the ovaries, cervix, fallopian tubes, and uterus. Different types of bacteria can cause this ...

A Paget’s disease, also known as Osteitis deformans, is a chronic bone disorder, which affects a single bone (monostotic) or multiple bones (poly-ostotic) resulting in abnormally long, weak, ...

Bromhidrosis, also known as osmidrosis, is a condition of abnormal or offensive body odor, determined by apocrine sweat gland secretion, although other sources may play a role. Bromhidrosis ...

Hirschsprung disease is known to affect colon and cause problems with stool excretion. This disease is hereditary due to absence of a critical nerve cell in the muscle ...

Addison’s disease, more commonly known as adrenal insufficiency, is a rare hormonal disorder wherein the adrenal gland produces little cortisol and aldosterone hormone as compared to the amount ...

Refsum disease is a genetic disease that is inherited as an autosomal recessive trait. The major cause of refsum disease is the accumulation of fatty acid (phytanic acid) ...

The global huntington's disease treatment market was valued at $315.2 million in 2021, and is projected to reach $707.5 million by 2031, growing at a CAGR of 8.4% from 2022 to 2031.

End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the U.S. Lysosomal Disease Treatment Market due to the outbreak of COVID-19.

The current Europe Lysosomal Disease Treatment Market is quantitatively analyzed from 2021 to 2031 to benchmark the financial competency.

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. End User was the leading segment.

The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

Research study titled U.K. Lysosomal Disease Treatment Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

The End User in France Lysosomal Disease Treatment Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

The End User segment in Spain Lysosomal Disease Treatment Market is expected to garner considerable share in terms of value and volume during the forecast period.

End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Japan Lysosomal Disease Treatment Market due to the outbreak of COVID-19.

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. End User was the leading segment.

The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.